Toll Free (US/Canada): 1-888-778-7886
Published: April 2017
Report Code: LS10911
Category : Medical Devices
HIV diagnosis refers to the test performed to detect the presence of human immunodeficiency virus (HIV) in humans. HIV attacks the immune system targeting CD4 cells, also known as T cells. T-cells helps the immune system to fight against infections. HIV weakens the immune system of an infected individual by reducing the number of T-cells leading to acquired immunodeficiency syndrome (AIDS). AIDS is the advanced stage of HIV infection, and not everyone suffering from HIV infection has AIDS. As reported by Centers for Disease Control and Prevention (CDC), people diagnosed with AIDS have their CD4 cell count below 200 cells/mm, and have high viral load. The global HIV diagnosis market has been segmented on the basis of product, application and end user.
On the basis of product, the global market has been segmented into consumable, instrument and software and services used for the diagnosis of HIV. Consumable has been the largest segment in the global HIV diagnosis market. Consumables include assays, kits, reagents and others. These kits are available as complete and convenient packed test systems and include a standard operating procedure (SOP). A patient has to follow the instructions carefully to get the desired results. Kits offer rapid, easy to use, sensitive, and reliable detection of HIV infection.
On the basis of type of test, the global HIV diagnosis market has been segmented into antibody test, viral load, CD4, early infant diagnosis and viral identification. Antibody test has been the largest segment in the global market. It further involves HIV-1 screening test, HIV-1 antibody confirmatory test and HIV-2 & group O test.
On the basis of end user, the market has been segmented into diagnostic laboratories, hospitals, research institutes and others. Others comprises of the gene banks, cell banks, biotechnology and pharmaceutical companies and home care settings. Diagnostic laboratories have been the largest end user of the global market.
The global HIV diagnosis market is expected to witness a CAGR of 10.6%, during the forecast period. Rising prevalence of HIV/AIDS, increasing awareness leading to blood donations and blood transfusions, and advantageous features of point of care instruments and kits are some of the key drivers for the global market growth. Increasing healthcare expenditure further supports the market growth. On the other hand, the market has been facing certain challenges such as high cost of automated HIV diagnosis procedure and stringent regulatory requirements, which may impede its growth, during the forecast period.
Increased participation of government associations has raised awareness regarding blood donations and blood transfusions, globally. Some of the major associations include WHO, International Federation of Red Cross and Red Crescent Societies (IFRC), AABB (formerly known as the American Association of Blood Banks) and American Red Cross. These organizations support blood donor programs and encourage people to donate blood and blood components. Moreover, various government initiatives have also been launched by these associations to increase awareness among people about blood donations. The World Blood Donor Day campaign launched by WHO, is celebrated every year on July 14. This initiative supports blood transfusion services around the world. These government associations and initiatives have boosted blood collections through voluntary donation around the world. According to WHO, approximately 92 million blood donations were reported annually in 2011 and the number reached to 108 million in 2014, globally. The compromised use of sterilized needles during blood transfusion leads to increased risk of HIV infection thus, serving as a major driver for the growth of the global HIV diagnosis market.
Some of the key players in the global HIV diagnosis market include Siemens AG, Hoffman La Roche Ltd., Danaher Corporation, Abbott Laboratories, Ltd., Thermo-Fisher Scientific Inc., Merck KGaA, Becton, Dickinson & Company, Alere Inc., Bio-Rad Laboratories and Hologic Inc.
P&S Market Research offers customization as per specific business requirements of clients. Illustrative customization within the scope of this report includes:
Place An Order